Hormone Therapy News

PHILADELPHIA — The number of women aged at least 50 years prescribed hormone therapy for menopause symptoms remains low, particularly for Hispanic women, despite good efficacy and safety, according to a presenter.

PHILADELPHIA — In a small study, more women with obesity reported vasomotor, genitourinary, mood and libido symptoms associated with menopause than their peers without obesity, according to a presenter.

PHILADELPHIA — In this video exclusive, Stephanie Faubion, MD, MBA, FACP, NCMP, IF, provides pearls for use of menopausal hormone therapy by women with chronic conditions.

PHILADELPHIA — In this video exclusive, Nanette Santoro, MD, discussed efficacy for different groups of women of a nonhormonal neurokinin 3 receptor antagonist recently approved by the FDA to treat moderate to severe hot flashes.

PHILADELPHIA — In this video exclusive, Cynthia A. Stuenkel, MD, MSCP, talks about selecting therapies for menopausal symptoms for women with a history of cardiovascular disease.

PHILADELPHIA — Age, race and education are the most prevalent barriers accounting for disparities in the prescription of menopausal HT, according to presenters.

State legislation prohibiting gender-confirming medical care for children and adolescents may lead to decreased access as pediatric endocrinology providers expressed concerns about their ability to practice in a survey.

Testosterone undecanoate therapy may not confer long-term benefits for men with impaired glucose tolerance and normal testosterone levels, according to a follow-up survey of participants in the T4DM trial.

Transgender and gender-diverse adults who received testosterone therapy immediately instead of after a standard care waiting period of 3 months had greater reductions in gender dysphoria, depression and suicidality, according to study data.

A large analysis of UK Biobank data indicated no increased CV risk from birth control and even suggested a potential cardioprotective effect from oral contraceptive use, researchers reported.